Security Snapshot

Cocrystal Pharma, Inc. - Common Stock, par value $0.001 per share (COCP) Institutional Ownership

CUSIP: 19188J409

13F Institutional Holders and Ownership History from Q4 2022 to Q1 2026

Latest Period

Q4 2025

Institutions Reporting

26

Shares (Excl. Options)

770,490

Price

$0.98

Save this security page for your next review

Keep this CUSIP in your watchlists so you can revisit quarter changes from one place.

Type / Class
Equity / Common Stock, par value $0.001 per share
Symbol
COCP on Nasdaq
Shares outstanding
13,831,528
Price per share
$1.43
All holders as of 31 Dec 2025
Q4 2025
Total 13F shares
770,490
Total reported value
$754,323
% of total 13F portfolios
0%
Share change
+53,208
Value change
+$52,087
Number of holders
26
Price from insider filings
$1.43
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Quick Takeaways

  • COCP - Cocrystal Pharma, Inc. - Common Stock, par value $0.001 per share is tracked under CUSIP 19188J409.
  • 26 institutions reported positions in Q4 2025.
  • 1 significant owner is listed from Schedule 13D/13G reporting.

What Changed

  • Holder count moved from 26 to 3 between Q4 2025 and Q1 2026.
  • Reported value moved from $754,323 to $540.

Why This Matters

  • You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
  • 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.

Source Evidence

Source: SEC Form 13F

Latest holder context comes from 26 institutions filings for Q4 2025.

Open SEC Evidence

Investment Quick Answers

What is CUSIP 19188J409?
CUSIP 19188J409 identifies COCP - Cocrystal Pharma, Inc. - Common Stock, par value $0.001 per share in SEC 13F datasets.

Where can I see the latest institutional holders?
Review the Q4 2025 holders report and the ownership history table below.

Significant Owners of Cocrystal Pharma, Inc. - Common Stock, par value $0.001 per share (COCP) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
FROST PHILLIP MD ET AL 18% +65% $3,078,992 +$1,349,571 2,462,012 +78% Phillip Frost, M.D. 28 Oct 2025

As of 31 Dec 2025, 26 institutional investors reported holding 770,490 shares of Cocrystal Pharma, Inc. - Common Stock, par value $0.001 per share (COCP). This represents 5.6% of the company’s total 13,831,528 outstanding shares.

Institutional Holders of Cocrystal Pharma, Inc. - Common Stock, par value $0.001 per share (COCP) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2026 Q1 535 $540 -$3,158 $1.01 3
2025 Q4 770,490 $754,323 +$52,087 $0.98 26
2025 Q3 664,982 $831,248 -$40,108 $1.25 21
2025 Q2 686,516 $1,022,928 -$87,903 $1.49 21
2025 Q1 748,773 $1,064,069 +$47,078 $1.42 23
2024 Q4 711,389 $1,437,038 -$15,989 $2.02 23
2024 Q3 719,274 $1,265,944 +$79,057 $1.76 19
2024 Q2 674,355 $1,571,278 -$90,505 $2.33 13
2024 Q1 721,322 $1,013,555 +$53,963 $1.40 14
2023 Q4 683,341 $1,173,672 -$35,542 $1.72 16
2023 Q3 704,225 $1,316,878 +$61,523 $1.87 15
2023 Q2 666,895 $1,594,259 -$144,985 $2.39 19
2023 Q1 738,638 $1,468,069 -$651,598 $1.99 19
2022 Q4 1,065,912 $2,076,645 +$2,076,610 $1.95 18
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .